Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration

By Riviere Kareen   Huang Zhaohua   Jerger Katherine   Macaraeg Nichole   Szoka Francis C.  

Journal of Drug Targeting, Vol. 19, Iss. 1, 2011-01 ,pp. : 14-24

Informa Healthcare

Access to resources Recommend Favorite

A combination of liposomal sunitinib plus liposomal irinotecan and liposome co-loaded with two drugs enhanced antitumor activity in PC12-bearing mouse

By Maitani Yoshie   Saito Hiroshi   Seishi Yuki   Iwase Yuko   Yamauchi Takayasu   Higashiyama Kimio   Sugino Takashi  

Journal of Drug Targeting, Vol. 20, Iss. 10, 2012-12 ,pp. : 873-882

Informa Healthcare

Access to resources Recommend Favorite

Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich’s carcinoma

By  

Canadian Journal of Physiology and Pharmacology, Vol. 93, Iss. 8, 2015-01 ,pp. : 695-708

NRC Research Press

Access to resources Recommend Favorite

Effect of Methylxanthine Derivatives on Doxorubicin Transport and Antitumor Activity

By  

Current Drug Metabolism, Vol. 2, Iss. 4, 2001-12 ,pp. : 379-395

Bentham Science Publishers

Access to resources Recommend Favorite

Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing

By  

Current Drug Delivery, Vol. 15, Iss. 9, 2018-11 ,pp. : 1261-1270

Bentham Science Publishers

Access to resources Recommend Favorite